Search Results - "Shen, R.R"

CD19 chimeric antigen receptor (CAR) engineered epstein-barr virus (EBV) specific T cells – an off-the-shelf, allogeneic CAR T-cell immunotherapy platform by Shen, R.R, Pham, C.D, Wu, M, Munson, D.J, Aftab, B.T

“…Background & AimChimeric antigen receptor (CAR) T cells have demonstrated potent antitumor efficacy in treating a range of B-cell malignancies, yet technical…”
Get full text

Emerging roles for the non-canonical IKKζ in cancer by Shen, R.R, Hahn, W.C

“…The IκB Kinase (IKK)-related kinases TBK1 and IKKζ have essential roles as regulators of innate immunity by modulating interferon and NF-κB signaling. Recent…”
Get full text

Gene expression profiling and TCR diversity of ATA188, a Pre-manufactured, Allogeneic Epstein-Barr Virus-targeted T-cell Immunotherapy for Patients with Multiple Sclerosis by Foubert, P., Srihari, S., Le Textier, L., Shen, R.R., Forozan, F., Smith, C., Khanna, R., Aftab, B.T.

“…There is increasing evidence that infection with the Epstein-Barr virus (EBV) plays a role in the development and pathogenesis of multiple sclerosis (MS). We…”
Get full text

LB792 IL4 suppresses skin barrier function by downregulating myosin light chain kinase (MLCK) and upregulating negative regulators of MLCK: Implication in atopic dermatitis pathogenesis by Shen, K., Zhang, Y., Bao, L., Doo, C., Yang, J.F., Shen, R.R., Yang, W., Chan, L.S.

Get full text

TRAF2 is an NF-κB-activating oncogene in epithelial cancers by Shen, R R, Zhou, A Y, Kim, E, O'Connell, J T, Hagerstrand, D, Beroukhim, R, Hahn, W C

“…Aberrant nuclear factor (NF)-κB activation is frequently observed in human cancers. Genome characterization efforts have identified genetic alterations in…”
Get full text

507 Diacerein alone and in combination with infliximab diminishes cytokine-mediated inflammation in an in vivo-equivalent cell culture psoriasis model by suppressing the pro-inflammatory effects of IL-17A, IL-22, Oncostatin-M, IL-1α, and TNF-α on keratinocytes by Doo, C., Bao, L., Shen, K., Yang, J.F., Shen, R.R., Chan, L.S.

Get full text

Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel correlates with response & survival in rituximab relapsing or refractory EBV posttransplant lymphoproliferative disease (PTLD) by Prockop, S., Shen, R.R., Guzman-Becerra, N., Sun, Y., Forozan, F., Doubrovina, E., O'Reilly, R.J., Li, X., Hiremath, M., Gamelin, L., Navarro, W., Aftab, B.T.

“…EBV PTLD is often a fatal disease. Tabelecleucel is an investigational off-theshelf, allogeneic T-cell immunotherapy specific for EBV antigens. Functional in…”
Get full text

Photocurrent and differential absorption spectra of InGaAsN single- and double-quantum-well structures grown by molecular beam epitaxy by Lay, T.S., Shen, R.R., Lin, E.Y., Kong, K.M., Chen, L.R., Wang, J.S., Lin, G., Chi, J.Y.

“…We report the photocurrent and differential absorption spectra of an InGaAsN single- and a double-quantum-well (SQW and DQW) structure measured at different…”
Get full text